Agenovir Corp said May 17 that it raised $10.6 million in a Series A financing led by Data Collective. Celgene Corp, Lightspeed Venture Partners and several individual investors also participated. Agenovir is developing antiviral therapeutics.
Source: PR newswire
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.